
Bioscience Discovery Evaluation Grant Program
The Bioscience Discovery Evaluation Grant Program was created by the Colorado legislature to foster development of the industry in Colorado, supporting both new business development and quality jobs for Coloradans. Grants to further develop technologies coming out of Colorado's non-profit, research institutions toward commercialization were authorized in statute in 2006.
Now in fiscal year 2011-12, the program continues to support technology transfer and commercialization with grants to qualified research institutions, to early-stage companies, and to fund critical infrastructure to grow the industry via partnership efforts between the bioscience industry and research institutions.
The Program Report highlights accomplishments and identifies grants made under the program.
The Proof-of-Concept grants under the Bioscience Discovery Evaluation Grant Program (BDEGP) are intended to support bioscience discoveries that will likely lead to the development of new products, services, businesses and employment in the bioscience industry in Colorado. Grants up to $150,000 are open to Offices of Technology Transfer (OTT) affiliated with qualified Research Institutions in order to enhance the commercial potential of bioscience research projects that focus on life sciences, engineering, material sciences computer sciences, photonics, or nanotechnology.
The Early-Stage Bioscience Company grants under the Bioscience Discovery Evaluation Grant Program are intended to spur economic development and help new companies born out of Colorado research institutions succeed in developing new technologies, business structures, and products. Grants up to $250,000 are accessible to qualified Early-Stage Companies whose technology is licensed from a qualified Research Institution. Grants will support the commercialization of therapeutic or diagnostic products, devices, or instruments to improve human health; bioscience technologies that improve agriculture; or biofuels.
Applications for the1st Grant Cycle for this fiscal year are due September 30, 2011.
Funds support partnership efforts between the bioscience industry and research institutions to build infrastructure that supports the commercialization of bioscience technologies in Colorado.
All funds have been committed to 4 projects with funding renewed annually through fiscal year 2012-13. The 2009 Application is provided for reference. OEDIT will update the program for fiscal year 2014.
The following documents may be useful in completing applications for the bioscience Early-Stage Company and Proof of Concept grants.
The Grant Agreement which all awardees are required to sign before funding is released is also included here. Grantees must accept and abide by these provisions.
For further information, please contact:
Sonya Guram , Program Manager
Colorado Office of Economic Development & International Trade
1625 Broadway, Suite 2700
Denver, Colorado 80202
(T) (303) 892-3840
(F) (303) 892-3848
1 (800) 659-2656 TDD
Secondary Contact:
Alice Kotrlik , Deputy Director